However, multivariate analysis revealed that methylation of DPYS, CCND2 and HSPB1 together added a substantial amount of prognostic information not captured by any other measure and therefore may be useful for improvement of prostate cancer management. The gene discussed is DPYS; the disease is prostate carcinoma.